Induction of nitric oxide synthase by protein synthesis inhibition in aortic smooth muscle cells

British Journal of Pharmacology

Volumn 123, Issue 5, 1998, Pages 1000-1008

  Marczin, Nándor ^a   Go, Carolyn Y ^a   Papapetropoulos, Andreas ^a   Catravas, John D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Anisomycin; Cyclic GMP; Cycloheximide; Nitric oxide; Repressor; Smooth muscle cells

Indexed keywords

ANISOMYCIN; CYCLIC GMP; CYCLOHEXIMIDE; DACTINOMYCIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; AORTA MEDIA; ARTICLE; ENZYME INDUCTION; GENE EXPRESSION; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031884547     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701687     Document Type: Article

References (34)

1. BEASLEY, D. (1990). Interleukin 1 and endotoxin activate soluble guanylate cyclase in vascular smooth muscle. Am. J. Physiol., 259, R38 - 44.
2. BEASLEY, D., COHEN, R.A. & LEVINSKY, N.G. (1989). Interleukin 1 inhibits contraction of vascular smooth muscle. J. Clin. Invest., 83, 331 - 335.
3. BEASLEY, D., SCHWARTZ, J.H. & BRENNER, B.M (1991). Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J. Clin. Invest., 87, 602 - 608.
4. BERGHAMMER, H. & AUER, B. (1993). "Easypreps": fast and easy plasmid minipreparation for analysis of recombinant clones in E. coli. Biotechniques, 14, 524 - 528.
5. BERNHARDT, J., TSCHUDI, M.R., DOHI, Y., GUT, I., URWYLER, B., BUHLER, F.R. & LUSCHER, T.F. (1991). Release of nitric oxide from human vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 180, 907 - 912.
6. BORRIELLO, F. & LEDERER, J. (1995). Construction of quantitative RT-PCR MIMICs. Biotechniques, 19, 580 - 584.
7. BUSSE, R. & MULSCH, A. (1990). Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett., 275, 87 - 90.
8. CANO, E., DOZA, Y.N., BEN LEVY, R., COHEN, P. & MAHADEVAN, L.C. (1996). Identification of anisomycin-activated kinases p45 and p55 in murine cells as MAPKAP kinase-2. Oncogene, 12, 805 - 812.
9. CANO, E., HAZZALIN, C.A., KARDALINOU, E., BUCKLE, R.S. & MAHADEVAN, L.C. (1995). Neither ERK nor JNK/SAPK/MAP kinase subtypes are essential for histone H3/HMG-14 phosphorylation or c-fos and c-jun induction. J. Cell Sci., 108, 3599 - 3609.
10. CANO, E., HAZZALIN, C.A. & MAHADEVAN, L.C. (1994). Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun. Mol. Cell Biol., 14, 7352 - 7362.
11. EDWARDS, D.R. & MAHADEVAN, L.C. (1992). Protein synthesis inhibitors differentially superinduce c-fos and c-jun by three distinct mechanisms: lack of evidence for labile repressors. EMBO J., 11, 2415 - 2424.
12. EVANS, T., CARPENTER, A. & COHEN, J. (1994). Inducible nitricoxide-synthase mRNA is transiently expressed and destroyed by a cycloheximide-sensitive process. Eur. J. Biochem., 219, 563 - 569.
13. FLEMING, I., GRAY, G.A., JULOU, SCHAEFFER, G., PARRATT, J.R. & STOCLET, J.C. (1990). Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem. Biophys. Res. Commun., 171, 562 - 568.
14. FLEMING, I., GRAY, G.A., SCHOTT, C. & STOCLET, J.C. (1991). Inducible but not constitutive production of nitric oxide by vascular smooth muscle cells. Eur. J. Pharmacol., 200, 375 - 376.
15. GEISTERFER, A.A., PEACH, M.J. & OWENS, G.K. (1988). Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res., 62, 749 - 756.
16. GHERSA, P., VAN HUIJSDUIJNEN, R.H., WHELAN, J. & DELAMARTER, J.F. (1992). Labile proteins play a dual role in the control of endothelial leukocyte adhesion molecule-1 (ELAM- 1) gene regulation. J. Biol. Chem., 267, 19226-19232.
17. GO, C., MARCZIN, N., DİENES-KADI, I., SNEAD, C. & CATRAVAS, J.D. (1994). Prolonged L-arginine-dependent cGMP accumulation and superinduction of NO generation by cycloheximide in vascular smooth muscle cells (abstract). FASEB J., 8, A314.
18. KANNO, K., HIRATA, Y., IMAI, T. & MARUMO, F. (1993). Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells. Hypertension, 22, 34 - 39.
19. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc. Natl. Acad. Sci. U.S.A., 87, 3629-3632.
20. G-methyl-L-arginine, an inhibitor of nitric oxide synthase. Biochem. Biophys. Res. Commun., 172, 1132-1138.
21. KNOWLES, R.G. & MONCADA, S. (1992). Nitric oxide as a signal in blood vessels. Trends Biochem. Sci., 17, 399-402.
22. KOIDE, M., KAWAHARA, Y., TSUDA, T. & YOKOYAMA, M. (1993). Cytokine-induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells. FEBS Lett., 318, 213-217.
23. MARCZIN, N., PAPAPETROPOULOS, A., JILLING, T. & CATRAVAS, J.D. (1993). Prevention of nitric oxide synthase induction in vascular smooth muscle cells by microtubule depolymerizing agents. Br. J. Pharmacol., 109, 603-605.
24. MARCZIN, N., RYAN, U.S. & CATRAVAS, J.D. (1992). Effects of oxidant stress on endothelium-derived relaxing factor-induced and nitrovasodilator-induced cGMP accumulation in vascular cells in culture. Circ. Res., 70, 326-340.
25. MCCARTHY, J.E. & KOLLMUS, H. (1995). Cytoplasmic mRNA-protein interactions in eukaryotic gene expression. Trends Biochem. Sci., 20, 191-197.
26. MONCADA, S. & HIGGS, E.A. (1991). Endogenous nitric oxide: Physiology, pathology and clinical relevance. Eur. J. Clin. Invest., 21, 361-374.
27. NATHAN, C. (1992). Nitric oxide as a secretory product of mammalian cells. FASEB J., 6, 3051-3064.
28. NUNOKAWA, Y., ISHIDA, N. & TANAKA, S. (1994). Promoter analysis of human inducible nitric oxide synthase gene associated with cardiovascular homeostasis. Biochem. Biophys. Res. Commun., 200, 802-807.
29. PETROS, A., BENNETT, D. & VALLANCE, P. (1991). Effect of nitricoxide synthase inhibitors on hypotension in patients with septic shock. Lancet., 338, 1557-1558.
30. OGUCHI, S., NEISZ, A. & ESUMI, H. (1994). Enhancement of inducible-type NO synthase gene transcription by protein synthesis inhibitors. Activation of an intracellular signal transduction pathway by low concentration of cyclohexamide. FEBS Lett., 338, 326-330.
31. REES, D.D., CELLEK, S., PALMER, R.M. & MONCADA, S. (1990). Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem. Biophys. Res. Commun., 173, 541-547.
32. SCHINI, V.B., DURANTE, W., ELIZONDO, E., SCOTT BURDEN, T., JUNQUERO, D.C., SCHAFER, A.I. & VANHOUTTE, P.M. (1992). The induction of nitric oxide synthase activity is inhibited by TGF-beta 1. PDGFAB and PDGFBB in vascular smooth muscle cells. Eur. J. Pharmacol., 216, 379-383.
33. SCHMIDT, H.H., LOHMANN, S.M. & WALTER, U. (1993). The nitricoxide and cGMP signal transduction system: regulation and mechanism of action. Biochim. Biophys. Acta. 1178, 153-175.
34. SIRSJO, A., SODERKVIST, P., SUNDQVIST, T., CARLSSON, M., OST, M. & GIDLOF, A. (1994). Different induction mechanisms of mRNA for inducible nitric oxide synthase in rat smooth muscle cells in culture and in aortic strips. FEBS Lett., 338, 191-196.